An investigational drug (Favipiravir) study for patients who have been hospitalized with the coronavirus COVID-19.
10 Studies found
Seeking men and women who have been hospitalized with the coronavirus COVID-19 for a study of an experimental drug.
This program provides access to investigational convalescent plasma for hospitalized patients infected with SARS-CoV-2 who have severe or life-threatening COVID-19, or who are judged by a healthcare provider to be at high risk of progression to severe or life-threatening disease.
Seeking people, local to central Massachusetts, who are fully recovered from the new coronavirus to sign up to donate plasma to help current COVID-19 patients.
Seeking men and women who are at high risk of developing COVID-19 following an exposure to an infected person for a study to evaluate whether convalescent plasma, which is made from blood donated from a person who has recovered from COVID-19, might prevent or lessen the severity of COVID-19.
Convalescent Plasma To Limit Coronavirus Associated Complications For People Being Treated Outside The Hospital
Seeking men and women who are being treated outside of the hospital for their COVID-19 infection for a study of an investigational blood product made from blood plasma donated by people who have recovered from COVID-19, known as convalescent plasma.
Seeking men and women who are in the hospital and diagnosed with COVID-19 for a study of an investigational drug to see if it acts as an anti-viral and anti-inflammatory treatment for COVID-19 infection.
Seeking people aged 12 and older who have been diagnosed with COVID-19 for an experimental treatment made from blood donated by people who have recovered from COVID-19.
Study Of An Investigational Dietary Supplement In People Treated Outside Of The Hospital For Covid-19 Infection
Seeking men and women whose mild to moderate COVID-19 infection is being treated outside of the hospital for a study of an investigational dietary supplement on the bacteria of their digestive system or gut microbiome.
Seeking hospitalized men and women who are receiving mechanical ventilation due to COVID-19 for a study to evaluate the efficacy and safety of an investigational drug.